A Daytona Beach serial killer will be the focus of a Law&Crime documentary to be featured at 9 p.m. eastern Friday, Nov. 21, on the A&E network as part of the series “Murder on Trial.” It will be ...

A prequel about Pennywise, currently streaming on HBO Max, has quietly become one of the most connected Stephen King projects on television. The series, It: Welcome to Derry, details how an ancient ...

Hello, Yahoo readers! My name is Brett Arnold, film critic and longtime Yahoo editor, and I'm back with another edition of Trust Me, I Watch Everything. And on streaming services you're likely already ...

Acquisition adds a new growth vertical to Abbott's already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. cancer screening and precision oncology diagnostics ...

Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...

Exact Sciences Corporation stock surged after Abbott Laboratories announces a $21bn acquisition at $105 per share, driven by Exact's cancer diagnostics leadership. Exact Sciences boasts strong revenue ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

MADISON, Wis. — Madison-based Exact Sciences, which leads the market with in-home cancer tests Cologuard and Oncotype DX, has been acquired by Abbott for around $21 billion. In the closing of the ...

MADISON, Wis. — Abbott agrees to acquire Exact Sciences for an estimated value up to $23 billion. The acquisition will include Exact Sciences’ cancer screening product lines Cologuard®, Oncotype DX®, ...

Abbott is acquiring Exact Sciences for $23 billion, the global healthcare leader announced on Thursday. Exact Sciences shareholders will receive $105 per common share, totaling approximately $21 ...